Cargando…

Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix

BACKGROUND: Papillary squamous cell carcinoma (PSCC) of the uterine cervix is difficult to diagnose due to its rarity and limited data regarding its clinical behavior. We attempted to assess the degree of stromal invasion using magnetic resonance imaging (MRI) and evaluate possible treatments for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagura, Michikazu, Koshiyama, Masafumi, Matsumura, Noriomi, Kido, Aki, Baba, Tsukasa, Abiko, Kaoru, Hamanishi, Junzo, Yamaguchi, Ken, Mikami, Yoshiki, Konishi, Ikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232646/
https://www.ncbi.nlm.nih.gov/pubmed/25348708
http://dx.doi.org/10.1186/1471-2407-14-784
_version_ 1782344606550065152
author Nagura, Michikazu
Koshiyama, Masafumi
Matsumura, Noriomi
Kido, Aki
Baba, Tsukasa
Abiko, Kaoru
Hamanishi, Junzo
Yamaguchi, Ken
Mikami, Yoshiki
Konishi, Ikuo
author_facet Nagura, Michikazu
Koshiyama, Masafumi
Matsumura, Noriomi
Kido, Aki
Baba, Tsukasa
Abiko, Kaoru
Hamanishi, Junzo
Yamaguchi, Ken
Mikami, Yoshiki
Konishi, Ikuo
author_sort Nagura, Michikazu
collection PubMed
description BACKGROUND: Papillary squamous cell carcinoma (PSCC) of the uterine cervix is difficult to diagnose due to its rarity and limited data regarding its clinical behavior. We attempted to assess the degree of stromal invasion using magnetic resonance imaging (MRI) and evaluate possible treatments for this lesion in view of its clinical behavior. METHODS: We analyzed 28 cases of PSCC diagnosed on the colposcopic selective biopsies. We studied the rate of accuracy of diagnoses of the colposcopic selective biopsies compared with the final diagnoses, and compared the rate of stromal invasion between the MRI and pathological findings while focusing on surgical methods and the clinical prognosis. RESULTS: Of the 28 patients, only 12 exhibited true PSCC. The other 16 patients were ultimately diagnosed with SCC or adenosquamous carcinoma based on the finding of the surgical specimens and exhibited relatively poor prognoses. Among the 12 true PSCC cases, the rate of diagnostic accuracy of stromal invasion (with or without) was only 58% (7/12) on the colposcopic selective biopsies. However, we were able to predict the presence of stromal invasion (microscopic borderline: approximately 3 mm) before surgery using MRI. None of the 10 patients treated with radical surgery displayed lymph node metastases. In addition, all 12 study patients exhibited no recurrence (mean: 49 months) and survived. CONCLUSIONS: MRI can be used to detect preinvasive and microinvasive disease before surgery. It is possible to select a less invasive surgical method than radical surgery in cases of preinvasive and microinvasive PSCC in view of the indolent clinical behavior of this disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-784) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4232646
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42326462014-11-16 Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix Nagura, Michikazu Koshiyama, Masafumi Matsumura, Noriomi Kido, Aki Baba, Tsukasa Abiko, Kaoru Hamanishi, Junzo Yamaguchi, Ken Mikami, Yoshiki Konishi, Ikuo BMC Cancer Research Article BACKGROUND: Papillary squamous cell carcinoma (PSCC) of the uterine cervix is difficult to diagnose due to its rarity and limited data regarding its clinical behavior. We attempted to assess the degree of stromal invasion using magnetic resonance imaging (MRI) and evaluate possible treatments for this lesion in view of its clinical behavior. METHODS: We analyzed 28 cases of PSCC diagnosed on the colposcopic selective biopsies. We studied the rate of accuracy of diagnoses of the colposcopic selective biopsies compared with the final diagnoses, and compared the rate of stromal invasion between the MRI and pathological findings while focusing on surgical methods and the clinical prognosis. RESULTS: Of the 28 patients, only 12 exhibited true PSCC. The other 16 patients were ultimately diagnosed with SCC or adenosquamous carcinoma based on the finding of the surgical specimens and exhibited relatively poor prognoses. Among the 12 true PSCC cases, the rate of diagnostic accuracy of stromal invasion (with or without) was only 58% (7/12) on the colposcopic selective biopsies. However, we were able to predict the presence of stromal invasion (microscopic borderline: approximately 3 mm) before surgery using MRI. None of the 10 patients treated with radical surgery displayed lymph node metastases. In addition, all 12 study patients exhibited no recurrence (mean: 49 months) and survived. CONCLUSIONS: MRI can be used to detect preinvasive and microinvasive disease before surgery. It is possible to select a less invasive surgical method than radical surgery in cases of preinvasive and microinvasive PSCC in view of the indolent clinical behavior of this disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-784) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-27 /pmc/articles/PMC4232646/ /pubmed/25348708 http://dx.doi.org/10.1186/1471-2407-14-784 Text en © Nagura et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Nagura, Michikazu
Koshiyama, Masafumi
Matsumura, Noriomi
Kido, Aki
Baba, Tsukasa
Abiko, Kaoru
Hamanishi, Junzo
Yamaguchi, Ken
Mikami, Yoshiki
Konishi, Ikuo
Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
title Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
title_full Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
title_fullStr Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
title_full_unstemmed Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
title_short Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
title_sort clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232646/
https://www.ncbi.nlm.nih.gov/pubmed/25348708
http://dx.doi.org/10.1186/1471-2407-14-784
work_keys_str_mv AT naguramichikazu clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT koshiyamamasafumi clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT matsumuranoriomi clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT kidoaki clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT babatsukasa clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT abikokaoru clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT hamanishijunzo clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT yamaguchiken clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT mikamiyoshiki clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix
AT konishiikuo clinicalapproachestotreatingpapillarysquamouscellcarcinomaoftheuterinecervix